Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
The Lancet. Neurology|September 21, 2016
Amyotrophic lateral sclerosis: moving towards a new classification systemAmmar Al-Chalabi, Orla Hardiman, Matthew C Kiernan, et al.
Annals of Neurology|September 15, 2010
Dextromethorphan plus ultra low-dose quinidine reduces pseudobulbar affectErik P Pioro, Benjamin Rix Brooks, Jeffrey Cummings, et al.
Respiratory Care|March 5, 2020
The Oral Secretion Scale and Prognostic Factors for Survival in Subjects With Amyotrophic Lateral SclerosisPamela A Cazzolli, Benjamin Rix Brooks, Yuki Nakayama, et al.
Nature Communications|February 20, 2021
Characterising open chromatin in chick embryos identifies cis-regulatory elements important for paraxial mesoderm formation and axis extensionGi Fay Mok, Leighton Folkes, Shannon A Weldon, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 4, 2022
A revision to the United States national ALS registry's algorithm to improve Case-AscertainmentPaul Mehta, Jaime Raymond, Moon Han, et al.
Scientific Reports|October 2, 2025
Gum Arabic modulates the microbiota-gut-brain axis and affects general fitness in zebrafishJustin Abi Assaf, Jean-Charles de Coriolis, Alice May Godden, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 12, 2021
Evidence for generalizability of edaravone efficacy using a novel machine learning risk-based subgroup analysis toolBenjamin Rix Brooks, Erik P Pioro, Danielle Beaulieu, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|March 3, 2010
Quality control of vital capacity as a primary outcome measure during phase III therapeutic clinical trial in amyotrophic lateral sclerosisMohammed Sanjak, Francois Salachas, Elizabeth Frija-Orvoen, et al.
Biological Reviews of the Cambridge Philosophical Society|February 22, 2021
Meiosis and beyond - understanding the mechanistic and evolutionary processes shaping the germline genomeRoberta Bergero, Peter Ellis, Wilfried Haerty, et al.
Neurodegenerative Disease Management|November 24, 2021
MN-166 (ibudilast) in amyotrophic lateral sclerosis in a Phase IIb/III study: COMBAT-ALS study designBjörn Oskarsson, Nicholas Maragakis, Richard S Bedlack, et al.
Pageof 11